Skip to Main content Skip to Navigation
Journal articles

Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease

Document type :
Journal articles
Complete list of metadatas

https://hal-mnhn.archives-ouvertes.fr/mnhn-02866469
Contributor : Jean-Paul Concordet <>
Submitted on : Friday, June 12, 2020 - 2:36:04 PM
Last modification on : Wednesday, September 23, 2020 - 10:48:02 AM

Links full text

Identifiers

Collections

Citation

Mohammad Ali Khosravi, Maryam Abbasalipour, Jean-Paul Concordet, Johannes Vom Berg, Sirous Zeinali, et al.. Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease. European Journal of Pharmacology, Elsevier, 2019, 854, pp.398-405. ⟨10.1016/j.ejphar.2019.04.042⟩. ⟨mnhn-02866469⟩

Share

Metrics

Record views

14